Kirsten Anderson

Kirsten Anderson has more than 25 years of experience in the biotech industry, with expertise in oncology drug development, providing strategic oversight and team leadership for clinical operations, regulatory affairs, pharmacovigilance and biometrics. Prior to joining Presage, Kirsten was VP of Clinical Operations at OncoGenex, and has held clinical trial management positions Sonus Pharmaceuticals, Xcyte Therapies, and Immunex. Kirsten earned a Master’s in Biotech Enterprise from Johns Hopkins and has a bachelor’s degree in biology from the University of Vermont.